NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-28 01:15 English 5.1 KB
2025-11-25 23:26
FORM S-8
English 68.9 KB
2025-11-25 23:24
FORM S-3/A
English 292.3 KB
2025-11-07 22:01
FORM 10-Q
English 1.8 MB
2025-11-04 03:39
FORM 4
English 9.6 KB
2025-11-04 03:38
FORM 4
English 9.3 KB
2025-11-04 03:38
FORM 4
English 8.6 KB
2025-10-23 03:27
FORM 4A
English 12.5 KB
2025-10-23 03:22
FORM 3A
English 12.1 KB
2025-10-22 22:09
8-K
English 141.3 KB
2025-10-21 13:00
8-K
English 73.9 KB
2025-10-21 03:42 English 10.3 KB
2025-10-21 03:42 English 10.5 KB
2025-10-21 03:40
FORM 4
English 8.5 KB
2025-10-21 03:39
FORM 4
English 12.0 KB

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mabion S.A. Logo
A CDMO providing end-to-end services for protein-based biotherapeutics.
Poland
MAB
MACROGENICS INC Logo
A biopharmaceutical company developing antibody-based therapeutics for cancer.
United States of America
MGNX
MADRIGAL PHARMACEUTICALS, INC. Logo
Biopharmaceutical company with the first FDA-approved treatment for the liver disease MASH.
United States of America
MDGL
Magle Chemoswed Holding AB Logo
A CDMO serving the pharma and medical device industries from development to manufacturing.
Sweden
MAGLE
MAIA Biotechnology, Inc. Logo
Clinical-stage immuno-oncology company developing telomere-targeting cancer therapies.
United States of America
MAIA
A molecular genetics diagnostics company developing tests for early cancer detection.
Germany
MYNZ
MANNKIND CORP Logo
Biopharmaceutical firm developing inhaled therapies for cardiometabolic/orphan lung diseases.
United States of America
MNKD
MARAVAI LIFESCIENCES HOLDINGS, INC. Logo
Life sciences company providing nucleic acid production and biologics safety testing.
United States of America
MRVI
Marinomed Biotech AG Logo
Develops treatments for viral infectious diseases and immunological disorders.
Austria
MARI
Marker Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing T cell-based immunotherapies.
United States of America
MRKR

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.